MiR-7, inhibited indirectly by LincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of breast cancer stem cells by downregulating the STAT3 pathway

Stem Cells

Volumn 32, Issue 11, 2014, Pages 2858-2868

  Zhang, Hongyi ^a   Cai, Kai ^a,b   Wang, Jing ^a   Wang, Xiaoying ^a   Cheng, Kai ^a,c   Shi, Fangfang ^a   Jiang, Longwei ^a,b   Zhang, Yunxia ^a   Dou, Jun ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b 81 Hospital of Chinese People's Liberation Army   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

Breast cancer stem cells; Epithelial mesenchymal transition; miR 7; SETDB1; Signal transducers and activators of transcription 3

Indexed keywords

HOTAIR LONG UNTRANSLATED RNA, HUMAN; MICRORNAS; MIRN7 MICRORNA, HUMAN; PROTEIN METHYLTRANSFERASES; RNA, LONG NONCODING; SETDB1 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN; STAT3 TRANSCRIPTION FACTOR;

BREAST NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; METABOLISM; NEOPLASTIC STEM CELLS; PATHOLOGY; PHYSIOLOGY;

BREAST NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MICRORNAS; NEOPLASTIC STEM CELLS; PROTEIN METHYLTRANSFERASES; RNA, LONG NONCODING; STAT3 TRANSCRIPTION FACTOR;

EID: 84907895333     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1795     Document Type: Article

References (47)

1. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN,. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 2007; 608: 1-22.
2. Chaffer CL, Weinberg RA,. A perspective on cancer cell metastasis. Science 2011; 331: 1559-1564.
3. Wang L, Wang J,. MicroRNA-mediated breast cancer metastasis: From primary site to distant organs. Oncogene 2012; 31: 2499-2511.
4. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988.
5. Charafe-Jauffret E, Ginestier C, Iovino F, et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 2010; 16: 45-55.
6. Wang J, Cao MG, You CZ, et al. A preliminary investigation of the relationship between circulating tumor cells and cancer stem cells in patients with breast cancer. Cell Mol Biol 2012; 58 Suppl: OL1641-1645.
7. Hughes L, Malone C, Chumsri S, et al. Characterisation of breast cancer cell lines and establishment of a novel isogenic subclone to study migration, invasion and tumourigenicity. Clin Exp Metastasis 2008; 25: 549-557.
8. Louie E, Nik S, Chen JS, et al. Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation. Breast Cancer Res 2010; 12: R94.
9. Scheel C, Weinberg RA,. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol 2012; 22: 396-403.
10. Polytarchou C, Iliopoulos D, Struhl K,. An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state. Proc Natl Acad Sci USA 2012; 109: 14470-14475.
11. Dou J, Gu N,. Emerging strategies for the identification and targeting of cancer stem cells. Tumour Biol 2010; 31: 243-253.
12. Oliveras-Ferraros C, Cufi S, Vazquez-Martin A, et al. Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: induction of the tumor suppressor miRNA let-7a and suppression of the TGFbeta-induced oncomiR miRNA-181a. Cell Cycle 2011; 10: 1144-1151.
13. Okuda H, Xing F, Pandey PR, et al. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Res 2013; 73: 1434-1444.
14. Foekens JA, Sieuwerts AM, Smid M, et al. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci USA 2008; 105: 13021-13026.
15. Matsui T, Leung D, Miyashita H, et al. Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature 2010; 464: 927-931.
16. Macgregor S, Montgomery GW, Liu JZ, et al. Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nat Genet 2011; 43: 1114-1118.
17. Ceol CJ, Houvras Y, Jane-Valbuena J, et al. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature 2011; 471: 513-517.
18. Rodriguez-Paredes M, Martinez, de Paz A, Simo-Riudalbas L, et al. Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis. Oncogene 2013.
19. Dou J, Pan M, Wen P, et al. Isolation and identification of cancer stem-like cells from murine melanoma cell lines. Cell Mol Immunol 2007; 4: 467-472.
20. Schriebl K, Satianegara G, Hwang A, et al. Selective removal of undifferentiated human embryonic stem cells using magnetic activated cell sorting followed by a cytotoxic antibody. Tissue Eng 2012; 18: 899-909.
21. Zhang H, Wang J, Cai K, et al. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells. J Cancer Res Therap 2012; 8: 226-231.
22. Kato K, Nomoto M, Izumi H, et al. Structure and functional analysis of the human STAT3 gene promoter: Alteration of chromatin structure as a possible mechanism for the upregulation in cisplatin-resistant cells. Biochim Biophys 2000; 1493: 91-100.
23. Marshall J,. Transwell((R)) invasion assays. Meth Mol Biol 2011; 769: 97-110.
24. Hou J, Lin L, Zhou W, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011; 19: 232-243.
25. Shi SR, Liu C, Young L, et al. Development of an optimal antigen retrieval protocol for immunohistochemistry of retinoblastoma protein (pRB) in formalin fixed, paraffin sections based on comparison of different methods. Biotech Histochem 2007; 82: 301-309.
26. Ng EK, Tsang WP, Ng SS, et al. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 2009; 101: 699-706.
27. Krek A, Grun D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet 2005; 37: 495-500.
28. Lewis BP, Burge CB, Bartel DP,. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
29. Davis FM, Azimi I, Faville RA, et al. Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent. Oncogene 2014; 33: 2307-2316.
30. Weigelt B, Peterse JL, van't Veer LJ,. Breast cancer metastasis: markers and models. Nature reviews. Cancer 2005; 5: 591-602.
31. Marotta LL, Almendro V, Marusyk A, et al. The JAK2/STAT3 signaling pathway is required for growth of CD44(+)CD24(-) stem cell-like breast cancer cells in human tumors. J Clin Invest 2011; 121: 2723-2735.
32. Vougier S, Cheung SH, Li L, et al. Anomalous behaviour of the STAT3 binding site in the human c-myc P2 promoter. BBRC 2007; 364: 627-632.
33. Ma L, Young J, Prabhala H, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nature Cell Biol 2010; 12: 247-256.
34. Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464: 1071-1076.
35. Reddy SD, Ohshiro K, Rayala SK, et al. MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res 2008; 68: 8195-8200.
36. Medema JP,. Cancer stem cells: the challenges ahead. Nature Cell Biol 2013; 15: 338-344.
37. Biddle A, Mackenzie IC,. Cancer stem cells and EMT in carcinoma. Cancer Metastasis Rev 2012.
38. Wang H, An W, Cao R, et al. mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression. Mol Cell 2003; 12: 475-487.
39. Rokavec M, Wu W, Luo JL,. IL6-mediated suppression of miR-200c directs constitutive activation of inflammatory signaling circuit driving transformation and tumorigenesis. Mol Cell 2012; 45: 777-789.
40. Fouse SD, Costello JF,. Cancer Stem Cells Activate STAT3 the EZ Way. Cancer Cell 2013; 23: 711-713.
41. Kim E, Kim M, Woo DH, et al. Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells. Cancer Cell 2013; 23: 839-852.
42. Duru N, Fan M, Candas D, et al. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells. Clinical cancer research: an official journal of the American Association for Cancer Research 2012; 18: 6634-6647.
43. Cheng GZ, Zhang WZ, Sun M, et al. Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function. JBC 2008; 283: 14665-14673.
44. Kong X, Li G, Yuan Y, et al. MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression. PloS ONE 2012; 7: e41523.
45. Zhang W, Zong CS, Hermanto U, et al. RACK1 recruits STAT3 specifically to insulin and insulin-like growth factor 1 receptors for activation, which is important for regulating anchorage-independent growth. MCB 2006; 26: 413-424.
46. Jiang L, Liu X, Chen Z, et al. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells. Biochem J 2010; 432: 199-205.
47. Wang Y, Xu Z, Jiang J, et al. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell 2013; 25: 69-80.